OpenAlex
PricingAboutJobs
Log inGet started
Work

Off-target effects of BCR–ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia

HTML

Year: 2012
Type: review
Source: Leukemia & lymphoma/Leukemia and lymphoma
DOI: 10.3109/10428194.2012.695779
Authors: Juan Luis Steegmann, Francisco Cervantes, Philipp le Coutre, Kimmo Porkka, Giuseppe Saglio
Institutions: Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Charité – Universitätsmedizin Berlin, University of Helsinki, Helsinki University Hospital, Ospedale San Luigi Gonzaga, University of Turin
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: chronic myeloid leukemia, BCR-ABL1 inhibitor, tyrosine kinase inhibitors, off-target effects, adverse events, imatinib, nilotinib, dasatinib, long-term drug safety, drug toxicity mechanisms
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2145835848
FWCI: 1.176
Cites: 108
Cited by: 121
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security